US 9655900
Heterocyclic compound
granted A61KA61K31/519A61K31/5377
Quick answer
US patent 9655900 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/519, A61K31/5377, A61K31/541, A61K31/55